| 1,1,1-trichloro-2,2-bis(4-hydroxyphenyl)ethane | multiple interactions | ISO | RGD:2872 | 6480464 | 2,2-bis(4-hydroxyphenyl)-1,1,1-trichloroethane affects the reaction [FSHB protein affects the expression of IGFBP1 mRNA] | CTD | PMID:19414516 |
| 1-methylphenanthrene | multiple interactions | ISO | RGD:69038 | 6480464 | [Benzo(a)pyrene co-treated with 1-methylphenanthrene] affects the expression of IGFBP1 mRNA | CTD | PMID:17690111 |
| 1-naphthyl isothiocyanate | increases expression | EXP | | 6480464 | 1-Naphthylisothiocyanate results in increased expression of IGFBP1 mRNA | CTD | PMID:15913567 |
| 1-naphthyl isothiocyanate | increases expression | ISO | RGD:2872 | 6480464 | 1-Naphthylisothiocyanate results in increased expression of IGFBP1 mRNA | CTD | PMID:18289764 PMID:17522070 |
| 1-naphthyl isothiocyanate | increases expression | ISO | RGD:2872 | 6480464 | 1-Naphthylisothiocyanate results in increased expression of IGFBP1 mRNA | CTD | PMID:17522070 PMID:18289764 |
| 17alpha-ethynylestradiol | increases expression | EXP | | 6480464 | Ethinyl Estradiol results in increased expression of IGFBP1 mRNA | CTD | PMID:14976129 |
| 17alpha-ethynylestradiol | multiple interactions | EXP | | 6480464 | [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of IGFBP1 mRNA | CTD | PMID:17942748 |
| 17alpha-ethynylestradiol | increases expression | ISO | RGD:2872 | 6480464 | Ethinyl Estradiol results in increased expression of IGFBP1 mRNA | CTD | PMID:15795090 |
| 17beta-estradiol | multiple interactions | ISO | RGD:69038 | 6480464 | [Progesterone co-treated with Estradiol] results in increased expression of IGFBP1 mRNA | CTD | PMID:17404688 |
| 17beta-estradiol | increases expression | ISO | RGD:69038 | 6480464 | Estradiol results in increased expression of IGFBP1 mRNA | CTD | PMID:12154049 |
| 17beta-estradiol | multiple interactions | ISO | RGD:69038 | 6480464 | [Estradiol deficiency co-treated with Medroxyprogesterone Acetate deficiency] results in decreased expression of IGFBP1 mRNA; more ... | CTD | PMID:11756571 |
| 17beta-estradiol | multiple interactions | ISO | RGD:69038 | 6480464 | [Estradiol co-treated with Medroxyprogesterone Acetate] results in increased expression of IGFBP1 | CTD | PMID:12093828 |
| 17beta-estradiol | multiple interactions | ISO | RGD:69038 | 6480464 | Progesterone inhibits the reaction [Estradiol results in increased expression of IGFBP1 protein] | CTD | PMID:17484513 |
| 17beta-estradiol | increases expression | ISO | RGD:69038 | 6480464 | Estradiol results in increased expression of IGFBP1 protein | CTD | PMID:17484513 |
| 2,2'-bipyridine | increases expression | ISO | RGD:69038 | 6480464 | 2,2'-Dipyridyl results in increased expression of IGFBP1 mRNA | CTD | PMID:19924283 |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | RGD:69038 | 6480464 | Tetrachlorodibenzodioxin results in increased expression of IGFBP1 mRNA | CTD | PMID:16697128 more ... |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | RGD:2872 | 6480464 | Tetrachlorodibenzodioxin results in increased expression of IGFBP1 mRNA | CTD | PMID:16054898 more ... |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | RGD:69038 | 6480464 | Tetrachlorodibenzodioxin results in increased expression of IGFBP1 mRNA | CTD | PMID:15056799 more ... |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | RGD:2872 | 6480464 | Tetrachlorodibenzodioxin results in increased expression of IGFBP1 mRNA | CTD | PMID:16054898 more ... |
| 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | RGD:2872 | 6480464 | Tetrachlorodibenzodioxin affects the expression of IGFBP1 mRNA | CTD | PMID:22298810 |
| 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | RGD:2872 | 6480464 | AHR protein alternative form affects the reaction [Tetrachlorodibenzodioxin results in increased expression of IGFBP1 mRNA] | CTD | PMID:21215274 |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in increased expression of IGFBP1 mRNA | CTD | PMID:16960034 more ... |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | RGD:69038 | 6480464 | Tetrachlorodibenzodioxin results in increased expression of IGFBP1 mRNA | CTD | PMID:15056799 more ... |
| 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | RGD:69038 | 6480464 | Tetrachlorodibenzodioxin affects the expression of IGFBP1 mRNA | CTD | PMID:22298810 |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | RGD:69038 | 6480464 | Tetrachlorodibenzodioxin results in increased expression of IGFBP1 mRNA | CTD | PMID:20106945 more ... |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | RGD:2872 | 6480464 | Tetrachlorodibenzodioxin results in increased expression of IGFBP1 mRNA | CTD | PMID:18178546 more ... |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in increased expression of IGFBP1 mRNA | CTD | PMID:16960034 more ... |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | RGD:69038 | 6480464 | Tetrachlorodibenzodioxin results in increased expression of IGFBP1 mRNA | CTD | PMID:15496506 more ... |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | RGD:2872 | 6480464 | Tetrachlorodibenzodioxin results in increased expression of IGFBP1 mRNA | CTD | PMID:19692669 more ... |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | RGD:69038 | 6480464 | Tetrachlorodibenzodioxin results in increased expression of IGFBP1 mRNA | CTD | PMID:16697128 more ... |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | RGD:2872 | 6480464 | Tetrachlorodibenzodioxin results in increased expression of IGFBP1 mRNA | CTD | PMID:19692669 more ... |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | RGD:69038 | 6480464 | Tetrachlorodibenzodioxin results in increased expression of IGFBP1 mRNA | CTD | PMID:20106945 more ... |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | RGD:2872 | 6480464 | Tetrachlorodibenzodioxin results in increased expression of IGFBP1 mRNA | CTD | PMID:16960034 more ... |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in increased expression of IGFBP1 mRNA | CTD | PMID:18827440 more ... |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | RGD:69038 | 6480464 | Tetrachlorodibenzodioxin results in increased expression of IGFBP1 mRNA | CTD | PMID:20106945 more ... |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | RGD:2872 | 6480464 | Tetrachlorodibenzodioxin results in increased expression of IGFBP1 mRNA | CTD | PMID:18178546 more ... |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in increased expression of IGFBP1 protein | CTD | PMID:18827440 |
| 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of IGFBP1 mRNA | CTD | PMID:17949056 |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in increased expression of IGFBP1 mRNA | CTD | PMID:18827440 more ... |
| 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | EXP | | 6480464 | [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of IGFBP1 mRNA | CTD | PMID:17942748 |
| 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | EXP | | 6480464 | AHR protein affects the reaction [Tetrachlorodibenzodioxin results in increased expression of IGFBP1 mRNA]; more ... | CTD | PMID:18827440 |
| 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | EXP | | 6480464 | 3'-methoxy-4'-nitroflavone inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of IGFBP1 mRNA] | CTD | PMID:19782052 |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | RGD:69038 | 6480464 | Tetrachlorodibenzodioxin results in increased expression of IGFBP1 protein | CTD | PMID:15496506 |
| 2,4-dinitrotoluene | affects expression | ISO | RGD:2872 | 6480464 | 2,4-dinitrotoluene affects the expression of IGFBP1 mRNA | CTD | PMID:21346803 |
| 2-amino-2-deoxy-D-galactopyranose | increases expression | ISO | RGD:2872 | 6480464 | Galactosamine results in increased expression of IGFBP1 mRNA | CTD | PMID:11779202 |
| 2-butoxyethanol | increases expression | EXP | | 6480464 | n-butoxyethanol results in increased expression of IGFBP1 mRNA | CTD | PMID:19812364 |
| 2-nitrofluorene | increases expression | ISO | RGD:2872 | 6480464 | 2-nitrofluorene results in increased expression of IGFBP1 mRNA | CTD | PMID:15890375 |
| 3,3',4,4',5-pentachlorobiphenyl | increases expression | ISO | RGD:2872 | 6480464 | 3,4,5,3',4'-pentachlorobiphenyl results in increased expression of IGFBP1 mRNA | CTD | PMID:19692669 |
| 3,3',4,4',5-pentachlorobiphenyl | increases expression | ISO | RGD:2872 | 6480464 | 3,4,5,3',4'-pentachlorobiphenyl results in increased expression of IGFBP1 mRNA | CTD | PMID:19692669 PMID:20959002 |
| 3H-1,2-dithiole-3-thione | decreases expression | ISO | RGD:2872 | 6480464 | 1,2-dithiol-3-thione results in decreased expression of IGFBP1 mRNA | CTD | PMID:19162173 |
| 4,4'-diaminodiphenylmethane | increases expression | ISO | RGD:2872 | 6480464 | 4,4'-diaminodiphenylmethane results in increased expression of IGFBP1 mRNA | CTD | PMID:18289764 |
| 4-(N-nitrosomethylamino)-1-(3-pyridyl)butan-1-one | increases expression | ISO | RGD:2872 | 6480464 | 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased expression of IGFBP1 mRNA | CTD | PMID:15890375 |
| 8-bromo-3',5'-cyclic AMP | increases secretion | ISO | RGD:69038 | 6480464 | 8-Bromo Cyclic Adenosine Monophosphate results in increased secretion of IGFBP1 protein | CTD | PMID:21273127 |
| 8-bromo-3',5'-cyclic AMP | multiple interactions | ISO | RGD:69038 | 6480464 | FOXO1 protein affects the reaction [[Medroxyprogesterone Acetate co-treated with 8-Bromo Cyclic Adenosine Monophosphate] results in increased secretion of IGFBP1 protein] | CTD | PMID:16709600 |
| 8-bromo-3',5'-cyclic AMP | increases expression | ISO | RGD:69038 | 6480464 | 8-Bromo Cyclic Adenosine Monophosphate results in increased expression of IGFBP1 mRNA | CTD | PMID:17065600 |
| 8-bromo-3',5'-cyclic AMP | multiple interactions | ISO | RGD:69038 | 6480464 | 1-Butanol inhibits the reaction [8-Bromo Cyclic Adenosine Monophosphate results in increased expression of IGFBP1 mRNA]; more ... | CTD | PMID:17065600 |
| afimoxifene | increases expression | ISO | RGD:69038 | 6480464 | 4-hydroxytamoxifen results in increased expression of IGFBP1 mRNA | CTD | PMID:12154049 |
| aflatoxin B1 | increases expression | ISO | RGD:2872 | 6480464 | Aflatoxin B1 results in increased expression of IGFBP1 mRNA | CTD | PMID:15890375 |
| aflatoxin B1 | increases expression | ISO | RGD:69038 | 6480464 | Aflatoxin B1 results in increased expression of IGFBP1 mRNA | CTD | PMID:21632981 PMID:21641981 |
| aflatoxin B1 | increases expression | ISO | RGD:69038 | 6480464 | Aflatoxin B1 results in increased expression of IGFBP1 mRNA | CTD | PMID:21641981 |
| aflatoxin B1 | affects expression | ISO | RGD:69038 | 6480464 | Aflatoxin B1 affects the expression of IGFBP1 protein | CTD | PMID:20106945 |
| ammonium chloride | affects expression | ISO | RGD:2872 | 6480464 | Ammonium Chloride affects the expression of IGFBP1 mRNA | CTD | PMID:16483693 |
| amphetamine | increases expression | ISO | RGD:2872 | 6480464 | Amphetamine results in increased expression of IGFBP1 mRNA | CTD | PMID:15183010 |
| Aroclor 1254 | increases expression | ISO | RGD:2872 | 6480464 | Chlorodiphenyl (54% Chlorine) results in increased expression of IGFBP1 mRNA | CTD | PMID:18178546 |
| bacitracin | increases expression | ISO | RGD:2872 | 6480464 | Bacitracin results in increased expression of IGFBP1 mRNA | CTD | PMID:18289764 |
| benzo[a]pyrene | multiple interactions | EXP | | 6480464 | [Benzo(a)pyrene co-treated with XPA gene mutant form co-treated with TRP53 gene mutant form] results in decreased expression of IGFBP1 mRNA | CTD | PMID:21715664 |
| benzo[a]pyrene | increases expression | ISO | RGD:69038 | 6480464 | Benzo(a)pyrene results in increased expression of IGFBP1 mRNA | CTD | PMID:16269432 more ... |
| benzo[a]pyrene | multiple interactions | ISO | RGD:69038 | 6480464 | [Benzo(a)pyrene co-treated with 1,2,5,6-dibenzanthracene] affects the expression of IGFBP1 mRNA; more ... | CTD | PMID:17690111 |
| benzo[a]pyrene | increases expression | ISO | RGD:69038 | 6480464 | Benzo(a)pyrene results in increased expression of IGFBP1 mRNA | CTD | PMID:20106945 more ... |
| benzo[a]pyrene | increases expression | ISO | RGD:69038 | 6480464 | Benzo(a)pyrene results in increased expression of IGFBP1 mRNA | CTD | PMID:20106945 more ... |
| benzo[a]pyrene | increases expression | ISO | RGD:69038 | 6480464 | Benzo(a)pyrene results in increased expression of IGFBP1 mRNA | CTD | PMID:21871943 PMID:20106945 |
| benzo[a]pyrene | increases expression | ISO | RGD:69038 | 6480464 | Benzo(a)pyrene results in increased expression of IGFBP1 mRNA | CTD | PMID:20106945 PMID:21871943 |
| benzo[a]pyrene | decreases expression | EXP | | 6480464 | Benzo(a)pyrene results in decreased expression of IGFBP1 mRNA | CTD | PMID:19770486 |
| benzo[a]pyrene | increases expression | ISO | RGD:69038 | 6480464 | Benzo(a)pyrene results in increased expression of IGFBP1 mRNA | CTD | PMID:20106945 |
| benzo[b]fluoranthene | multiple interactions | ISO | RGD:69038 | 6480464 | [Benzo(a)pyrene co-treated with benzo(b)fluoranthene] affects the expression of IGFBP1 mRNA | CTD | PMID:17690111 |
| benzo[b]fluoranthene | increases expression | ISO | RGD:69038 | 6480464 | benzo(b)fluoranthene results in increased expression of IGFBP1 mRNA | CTD | PMID:16269432 |
| bicalutamide | multiple interactions | ISO | RGD:69038 | 6480464 | [bicalutamide co-treated with Tamoxifen] results in increased expression of IGFBP1 protein | CTD | PMID:16847815 |
| bis(2-ethylhexyl) phthalate | increases expression | EXP | | 6480464 | Diethylhexyl Phthalate results in increased expression of IGFBP1 mRNA | CTD | PMID:19850644 |
| bis(2-ethylhexyl) phthalate | multiple interactions | EXP | | 6480464 | PPARA protein inhibits the reaction [Diethylhexyl Phthalate results in increased expression of IGFBP1 mRNA] | CTD | PMID:19850644 |
| bisphenol A | increases expression | ISO | RGD:69038 | 6480464 | bisphenol A results in increased expression of IGFBP1 mRNA; more ... | CTD | PMID:21273127 |
| bucladesine | increases expression | ISO | RGD:69038 | 6480464 | Bucladesine results in increased expression of IGFBP1 | CTD | PMID:12093828 |
| butan-1-ol | multiple interactions | ISO | RGD:69038 | 6480464 | 1-Butanol inhibits the reaction [8-Bromo Cyclic Adenosine Monophosphate results in increased expression of IGFBP1 mRNA] | CTD | PMID:17065600 |
| C60 fullerene | decreases expression | ISO | RGD:2872 | 6480464 | fullerene C60 results in decreased expression of IGFBP1 mRNA | CTD | PMID:19167457 |
| caffeine | increases expression | ISO | RGD:69038 | 6480464 | Caffeine results in increased expression of IGFBP1 mRNA | CTD | PMID:11793227 |
| calcitriol | increases expression | ISO | RGD:69038 | 6480464 | Calcitriol results in increased expression of IGFBP1 mRNA | CTD | PMID:21592394 |
| calcitriol | multiple interactions | ISO | RGD:69038 | 6480464 | [Testosterone co-treated with Calcitriol] results in increased expression of IGFBP1 mRNA | CTD | PMID:21592394 |
| chenodeoxycholic acid | decreases expression | EXP | | 6480464 | Chenodeoxycholic Acid results in decreased expression of IGFBP1 mRNA | CTD | PMID:19072826 |
| chlorpromazine | increases expression | ISO | RGD:69038 | 6480464 | Chlorpromazine results in increased expression of IGFBP1 mRNA | CTD | PMID:15924885 |
| cholesterol | multiple interactions | EXP | | 6480464 | [Cholesterol co-treated with 1,2-dioleoyloxy-3-(trimethylammonium)propane] results in increased expression of IGFBP1 mRNA | CTD | PMID:22129739 |
| choline | multiple interactions | EXP | | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of IGFBP1 mRNA | CTD | PMID:20938992 |
| ciguatoxin CTX1B | affects expression | EXP | | 6480464 | Ciguatoxins affects the expression of IGFBP1 mRNA | CTD | PMID:18353800 |
| ciprofibrate | increases expression | EXP | | 6480464 | ciprofibrate results in increased expression of IGFBP1 mRNA | CTD | PMID:12771043 |
| cis-ketoconazole | increases expression | ISO | RGD:2872 | 6480464 | Ketoconazole results in increased expression of IGFBP1 mRNA | CTD | PMID:18289764 |
| cisplatin | affects expression | ISO | RGD:2872 | 6480464 | Cisplatin affects the expression of IGFBP1 mRNA | CTD | PMID:18289764 |
| clofibrate | increases expression | ISO | RGD:2872 | 6480464 | Clofibrate results in increased expression of IGFBP1 mRNA | CTD | PMID:17522070 |
| clofibrate | decreases expression | EXP | | 6480464 | Clofibrate results in decreased expression of IGFBP1 mRNA | CTD | PMID:17585979 |
| clofibrate | multiple interactions | EXP | | 6480464 | [Clofibrate co-treated with Acetaminophen] affects the expression of IGFBP1 mRNA; more ... | CTD | PMID:17585979 |
| clofibrate | increases expression | EXP | | 6480464 | Clofibrate results in increased expression of IGFBP1 mRNA | CTD | PMID:11356909 |
| clotrimazole | increases expression | ISO | RGD:69038 | 6480464 | Clotrimazole results in increased expression of IGFBP1 mRNA | CTD | PMID:12659874 |
| clotrimazole | increases secretion | ISO | RGD:69038 | 6480464 | Clotrimazole results in increased secretion of IGFBP1 protein | CTD | PMID:12659874 |
| cobalt dichloride | increases expression | EXP | | 6480464 | cobaltous chloride results in increased expression of IGFBP1 mRNA; more ... | CTD | PMID:16990490 |
| cobalt dichloride | decreases expression | EXP | | 6480464 | cobaltous chloride results in decreased expression of IGFBP1 mRNA | CTD | PMID:21139344 |
| copper(2+) sulfate | increases expression | ISO | RGD:69038 | 6480464 | Copper Sulfate results in increased expression of IGFBP1 mRNA | CTD | PMID:19549813 |
| cyclosporin A | increases expression | ISO | RGD:69038 | 6480464 | Cyclosporine results in increased expression of IGFBP1 mRNA | CTD | PMID:20106945 |
| cyclosporin A | increases expression | ISO | RGD:69038 | 6480464 | Cyclosporine results in increased expression of IGFBP1 mRNA | CTD | PMID:20106945 PMID:21632981 |
| cyclosporin A | increases expression | ISO | RGD:2872 | 6480464 | Cyclosporine results in increased expression of IGFBP1 mRNA | CTD | PMID:21865292 |
| cyclosporin A | decreases expression | ISO | RGD:2872 | 6480464 | Cyclosporine results in decreased expression of IGFBP1 mRNA | CTD | PMID:21865292 |
| dexamethasone | multiple interactions | ISO | RGD:69038 | 6480464 | [Dexamethasone results in increased phosphorylation of and results in increased activity of NR3C1 protein] which results in increased expression of IGFBP1 mRNA | CTD | PMID:18483179 |
| dexamethasone | increases expression | ISO | RGD:2872 | 6480464 | Dexamethasone results in increased expression of IGFBP1 mRNA | CTD | PMID:17522070 |
| diarsenic trioxide | increases expression | EXP | | 6480464 | arsenic trioxide results in increased expression of IGFBP1 mRNA | CTD | PMID:15073043 |
| dibenz[a,h]anthracene | increases expression | ISO | RGD:69038 | 6480464 | 1,2,5,6-dibenzanthracene results in increased expression of IGFBP1 mRNA | CTD | PMID:16269432 |
| dibenz[a,h]anthracene | multiple interactions | ISO | RGD:69038 | 6480464 | [Benzo(a)pyrene co-treated with 1,2,5,6-dibenzanthracene] affects the expression of IGFBP1 mRNA | CTD | PMID:17690111 |
| dibenzo[a,l]pyrene | increases expression | ISO | RGD:69038 | 6480464 | dibenzo(a,l)pyrene results in increased expression of IGFBP1 mRNA | CTD | PMID:16269432 |
| dibenzo[a,l]pyrene | multiple interactions | ISO | RGD:69038 | 6480464 | [Benzo(a)pyrene co-treated with dibenzo(a,l)pyrene] affects the expression of IGFBP1 mRNA | CTD | PMID:17690111 |
| diethylstilbestrol | multiple interactions | EXP | | 6480464 | [Diethylstilbestrol co-treated with sodium arsenite] results in increased expression of IGFBP1 mRNA | CTD | PMID:19665456 |
| diethylstilbestrol | increases expression | ISO | RGD:2872 | 6480464 | Diethylstilbestrol results in increased expression of IGFBP1 mRNA | CTD | PMID:15890375 |
| dimethylarsinic acid | increases expression | EXP | | 6480464 | Cacodylic Acid results in increased expression of IGFBP1 mRNA | CTD | PMID:15345372 |
| dioxygen | increases expression | ISO | RGD:69038 | 6480464 | Oxygen deficiency results in increased expression of IGFBP1 mRNA | CTD | PMID:19924283 |
| enalapril | increases expression | ISO | RGD:2872 | 6480464 | Enalapril results in increased expression of IGFBP1 mRNA | CTD | PMID:12883983 |
| erythromycin estolate | increases expression | ISO | RGD:2872 | 6480464 | Erythromycin Estolate results in increased expression of IGFBP1 mRNA | CTD | PMID:17522070 |
| ethanol | decreases expression | EXP | | 6480464 | Ethanol results in decreased expression of IGFBP1 mRNA | CTD | PMID:19167417 |
| folic acid | multiple interactions | EXP | | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of IGFBP1 mRNA | CTD | PMID:20938992 |
| fumonisin B1 | increases expression | EXP | | 6480464 | fumonisin B1 results in increased expression of IGFBP1 mRNA | CTD | PMID:16221962 |
| genistein | decreases expression | ISO | RGD:2872 | 6480464 | Genistein results in decreased expression of IGFBP1 mRNA | CTD | PMID:17049845 |
| genistein | increases expression | ISO | RGD:2872 | 6480464 | Genistein results in increased expression of IGFBP1 mRNA | CTD | PMID:15795090 |
| hydrogen peroxide | multiple interactions | ISO | RGD:2872 | 6480464 | Hydrogen Peroxide inhibits the reaction [INS1 protein results in decreased expression of IGFBP1 mRNA] | CTD | PMID:17213664 |
| indole-3-methanol | multiple interactions | ISO | RGD:2872 | 6480464 | Acetylcysteine inhibits the reaction [[indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of IGFBP1 mRNA] | CTD | PMID:22129741 |
| ketamine | increases expression | ISO | RGD:2872 | 6480464 | Ketamine results in increased expression of IGFBP1 mRNA | CTD | PMID:20080153 |
| L-methionine | multiple interactions | EXP | | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of IGFBP1 mRNA | CTD | PMID:20938992 |
| lead diacetate | increases expression | EXP | | 6480464 | lead acetate results in increased expression of IGFBP1 mRNA | CTD | PMID:21335049 |
| lisinopril dihydrate | increases expression | ISO | RGD:69038 | 6480464 | Lisinopril results in increased expression of IGFBP1 protein | CTD | PMID:9663927 |
| medroxyprogesterone acetate | increases expression | ISO | RGD:69038 | 6480464 | Medroxyprogesterone Acetate results in increased expression of IGFBP1 mRNA | CTD | PMID:20685861 |
| medroxyprogesterone acetate | increases expression | ISO | RGD:69038 | 6480464 | Medroxyprogesterone Acetate results in increased expression of IGFBP1 mRNA | CTD | PMID:11756571 PMID:20685861 |
| medroxyprogesterone acetate | increases expression | ISO | RGD:69038 | 6480464 | Medroxyprogesterone Acetate results in increased expression of IGFBP1 mRNA | CTD | PMID:20685861 PMID:11756571 |
| medroxyprogesterone acetate | multiple interactions | ISO | RGD:69038 | 6480464 | [Estradiol co-treated with Medroxyprogesterone Acetate] results in increased expression of IGFBP1 mRNA; more ... | CTD | PMID:11756571 |
| medroxyprogesterone acetate | multiple interactions | ISO | RGD:69038 | 6480464 | [Estradiol co-treated with Medroxyprogesterone Acetate] results in increased expression of IGFBP1 | CTD | PMID:12093828 |
| medroxyprogesterone acetate | multiple interactions | ISO | RGD:69038 | 6480464 | [Medroxyprogesterone Acetate co-treated with 8-Bromo Cyclic Adenosine Monophosphate] results in increased secretion of IGFBP1 protein; more ... | CTD | PMID:16709600 |
| methapyrilene | increases expression | ISO | RGD:2872 | 6480464 | Methapyrilene results in increased expression of IGFBP1 mRNA | CTD | PMID:15120968 PMID:15890375 |
| methapyrilene | increases expression | ISO | RGD:2872 | 6480464 | Methapyrilene results in increased expression of IGFBP1 mRNA | CTD | PMID:15890375 PMID:15120968 |
| methylarsonic acid | increases expression | EXP | | 6480464 | monomethylarsonic acid results in increased expression of IGFBP1 mRNA | CTD | PMID:15345372 |
| methylmercury(1+) | decreases expression | ISO | RGD:2872 | 6480464 | methylmercury II results in decreased expression of IGFBP1 mRNA | CTD | PMID:17905399 |
| microcystin-LR | increases expression | EXP | | 6480464 | cyanoginosin LR results in increased expression of IGFBP1 mRNA | CTD | PMID:17654400 |
| N-acetyl-L-cysteine | multiple interactions | ISO | RGD:2872 | 6480464 | Acetylcysteine inhibits the reaction [[indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of IGFBP1 mRNA] | CTD | PMID:22129741 |
| N-nitrosodiethylamine | increases expression | ISO | RGD:69038 | 6480464 | Diethylnitrosamine results in increased expression of IGFBP1 mRNA | CTD | PMID:21527772 |
| N-nitrosodiethylamine | multiple interactions | ISO | RGD:2872 | 6480464 | Acetylcysteine inhibits the reaction [[indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of IGFBP1 mRNA] | CTD | PMID:22129741 |
| N-nitrosodiethylamine | increases expression | EXP | | 6480464 | Diethylnitrosamine results in increased expression of IGFBP1 mRNA | CTD | PMID:17942915 PMID:12771043 |
| N-nitrosodiethylamine | increases expression | ISO | RGD:2872 | 6480464 | Diethylnitrosamine results in increased expression of IGFBP1 mRNA | CTD | PMID:19638242 |
| N-nitrosodiethylamine | multiple interactions | EXP | | 6480464 | MET protein inhibits the reaction [Diethylnitrosamine results in increased expression of IGFBP1 mRNA] | CTD | PMID:17942915 |
| N-nitrosodiethylamine | increases expression | EXP | | 6480464 | Diethylnitrosamine results in increased expression of IGFBP1 mRNA | CTD | PMID:12771043 PMID:17942915 |
| N-nitrosodimethylamine | increases expression | ISO | RGD:2872 | 6480464 | Dimethylnitrosamine results in increased expression of IGFBP1 mRNA | CTD | PMID:15890375 |
| N-nitrosodimethylamine | decreases expression | ISO | RGD:2872 | 6480464 | Dimethylnitrosamine results in decreased expression of IGFBP1 mRNA | CTD | PMID:17072980 |
| nickel dichloride | increases expression | ISO | RGD:69038 | 6480464 | nickel chloride results in increased expression of IGFBP1 mRNA | CTD | PMID:21455298 |
| nicotinamide | multiple interactions | EXP | | 6480464 | Niacinamide inhibits the reaction [FOXO1 protein results in increased expression of IGFBP1 mRNA] | CTD | PMID:16917544 |
| ochratoxin A | decreases expression | ISO | RGD:69038 | 6480464 | ochratoxin A results in decreased expression of IGFBP1 mRNA; more ... | CTD | PMID:19287073 |
| ochratoxin A | increases expression | ISO | RGD:2872 | 6480464 | ochratoxin A results in increased expression of IGFBP1 mRNA | CTD | PMID:19717638 |
| oxazepam | increases expression | EXP | | 6480464 | Oxazepam results in increased expression of IGFBP1 protein | CTD | PMID:12727805 |
| oxazepam | increases expression | EXP | | 6480464 | Oxazepam results in increased expression of IGFBP1 mRNA | CTD | PMID:15618236 PMID:12727805 |
| oxazepam | increases expression | EXP | | 6480464 | Oxazepam results in increased expression of IGFBP1 mRNA | CTD | PMID:12727805 PMID:15618236 |
| ozone | decreases expression | EXP | | 6480464 | Ozone results in decreased expression of IGFBP1 mRNA | CTD | PMID:16183385 |
| paracetamol | increases expression | EXP | | 6480464 | Acetaminophen results in increased expression of IGFBP1 mRNA | CTD | PMID:17585979 |
| paracetamol | increases expression | ISO | RGD:2872 | 6480464 | Acetaminophen results in increased expression of IGFBP1 mRNA | CTD | PMID:17522070 more ... |
| paracetamol | increases expression | ISO | RGD:2872 | 6480464 | Acetaminophen results in increased expression of IGFBP1 mRNA | CTD | PMID:17202762 more ... |
| paracetamol | affects expression | EXP | | 6480464 | Acetaminophen affects the expression of IGFBP1 mRNA | CTD | PMID:15606129 PMID:17562736 |
| paracetamol | increases expression | ISO | RGD:2872 | 6480464 | Acetaminophen results in increased expression of IGFBP1 mRNA | CTD | PMID:17522070 more ... |
| paracetamol | increases expression | ISO | RGD:2872 | 6480464 | Acetaminophen results in increased expression of IGFBP1 mRNA | CTD | PMID:15120968 more ... |
| paracetamol | affects expression | EXP | | 6480464 | Acetaminophen affects the expression of IGFBP1 mRNA | CTD | PMID:17562736 PMID:15606129 |
| paracetamol | increases expression | ISO | RGD:69038 | 6480464 | Acetaminophen results in increased expression of IGFBP1 mRNA | CTD | PMID:11793227 |
| paracetamol | multiple interactions | EXP | | 6480464 | PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of IGFBP1 mRNA] | CTD | PMID:17585979 |
| paraquat | multiple interactions | ISO | RGD:2872 | 6480464 | Paraquat inhibits the reaction [INS1 protein results in decreased expression of IGFBP1 mRNA] | CTD | PMID:17213664 |
| phenobarbital | multiple interactions | EXP | | 6480464 | NR1I3 protein affects the reaction [Phenobarbital results in increased expression of IGFBP1 mRNA] | CTD | PMID:19482888 |
| phenobarbital | affects expression | ISO | RGD:69038 | 6480464 | Phenobarbital affects the expression of IGFBP1 mRNA | CTD | PMID:19084549 PMID:19159669 |
| phenobarbital | affects expression | ISO | RGD:69038 | 6480464 | Phenobarbital affects the expression of IGFBP1 mRNA | CTD | PMID:19084549 |
| phenobarbital | increases secretion | ISO | RGD:69038 | 6480464 | Phenobarbital results in increased secretion of IGFBP1 protein | CTD | PMID:12659874 |
| phenobarbital | increases expression | ISO | RGD:69038 | 6480464 | Phenobarbital results in increased expression of IGFBP1 mRNA | CTD | PMID:12659874 |
| phenobarbital | increases expression | ISO | RGD:2872 | 6480464 | Phenobarbital results in increased expression of IGFBP1 mRNA | CTD | PMID:19162173 |
| phenobarbital | increases expression | EXP | | 6480464 | Phenobarbital results in increased expression of IGFBP1 mRNA | CTD | PMID:19482888 |
| phorbol 13-acetate 12-myristate | multiple interactions | EXP | | 6480464 | [sodium arsenite co-treated with Tetradecanoylphorbol Acetate] results in increased expression of IGFBP1 mRNA | CTD | PMID:16368122 |
| phorone | affects expression | ISO | RGD:2872 | 6480464 | phorone affects the expression of IGFBP1 mRNA | CTD | PMID:18198479 |
| piperonyl butoxide | increases expression | ISO | RGD:2872 | 6480464 | Piperonyl Butoxide results in increased expression of IGFBP1 mRNA | CTD | PMID:15890375 |
| pirinixic acid | multiple interactions | EXP | | 6480464 | [pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of IGFBP1 mRNA | CTD | PMID:19710929 |
| pirinixic acid | increases expression | EXP | | 6480464 | pirinixic acid results in increased expression of IGFBP1 mRNA | CTD | PMID:12727805 more ... |
| pirinixic acid | increases expression | EXP | | 6480464 | pirinixic acid results in increased expression of IGFBP1 mRNA | CTD | PMID:18445702 more ... |
| pirinixic acid | increases expression | EXP | | 6480464 | pirinixic acid results in increased expression of IGFBP1 mRNA | CTD | PMID:15618236 more ... |
| pirinixic acid | increases expression | ISO | RGD:2872 | 6480464 | pirinixic acid results in increased expression of IGFBP1 mRNA | CTD | PMID:15890375 |
| pirinixic acid | increases expression | EXP | | 6480464 | pirinixic acid results in increased expression of IGFBP1 protein | CTD | PMID:12727805 |
| pirinixic acid | increases expression | EXP | | 6480464 | pirinixic acid results in increased expression of IGFBP1 mRNA | CTD | PMID:18445702 more ... |
| pregnenolone 16alpha-carbonitrile | decreases expression | ISO | RGD:2872 | 6480464 | Pregnenolone Carbonitrile results in decreased expression of IGFBP1 mRNA | CTD | PMID:19162173 |
| pregnenolone 16alpha-carbonitrile | decreases expression | EXP | | 6480464 | Pregnenolone Carbonitrile results in decreased expression of IGFBP1 mRNA | CTD | PMID:22698814 |
| progesterone | affects expression | ISO | RGD:69038 | 6480464 | Progesterone affects the expression of IGFBP1 mRNA; more ... | CTD | PMID:15501902 |
| progesterone | multiple interactions | ISO | RGD:69038 | 6480464 | Progesterone inhibits the reaction [Estradiol results in increased expression of IGFBP1 protein] | CTD | PMID:17484513 |
| progesterone | increases expression | ISO | RGD:69038 | 6480464 | Progesterone results in increased expression of IGFBP1 mRNA | CTD | PMID:17404688 |
| progesterone | multiple interactions | ISO | RGD:69038 | 6480464 | [Progesterone co-treated with Estradiol] results in increased expression of IGFBP1 mRNA | CTD | PMID:17404688 |
| quercetin | decreases expression | ISO | RGD:69038 | 6480464 | Quercetin results in decreased expression of IGFBP1 mRNA | CTD | PMID:21632981 |
| quinolin-8-ol | increases expression | ISO | RGD:69038 | 6480464 | Oxyquinoline results in increased expression of IGFBP1 mRNA | CTD | PMID:21632981 |
| resveratrol | multiple interactions | ISO | RGD:2872 | 6480464 | resveratrol inhibits the reaction [INS1 protein results in decreased expression of IGFBP1 mRNA] | CTD | PMID:16626303 |
| resveratrol | increases expression | ISO | RGD:69038 | 6480464 | resveratrol results in increased expression of IGFBP1 mRNA | CTD | PMID:12154049 |
| resveratrol | multiple interactions | EXP | | 6480464 | resveratrol promotes the reaction [FOXO1 protein results in increased expression of IGFBP1 mRNA] | CTD | PMID:16917544 |
| resveratrol | increases expression | ISO | RGD:2872 | 6480464 | resveratrol results in increased expression of IGFBP1 mRNA | CTD | PMID:16236254 |
| resveratrol | multiple interactions | ISO | RGD:2872 | 6480464 | FOXO1 protein affects the reaction [resveratrol results in increased expression of IGFBP1 mRNA] | CTD | PMID:15788402 |
| riddelliine | increases expression | ISO | RGD:2872 | 6480464 | riddelliine results in increased expression of IGFBP1 mRNA | CTD | PMID:18047727 |
| rifampicin | multiple interactions | ISO | RGD:69038 | 6480464 | [Rifampin co-treated with NR1I2 protein] results in increased expression of IGFBP1 mRNA | CTD | PMID:21127053 |
| S-butyl-DL-homocysteine (S,R)-sulfoximine | multiple interactions | ISO | RGD:2872 | 6480464 | Buthionine Sulfoximine inhibits the reaction [INS1 protein results in decreased expression of IGFBP1 mRNA] | CTD | PMID:17213664 |
| sirolimus | increases expression | ISO | RGD:2872 | 6480464 | Sirolimus results in increased expression of IGFBP1 mRNA | CTD | PMID:21865292 |
| stavudine | increases expression | ISO | RGD:2872 | 6480464 | Stavudine results in increased expression of IGFBP1 mRNA | CTD | PMID:18299183 |
| tacrolimus hydrate | decreases expression | ISO | RGD:2872 | 6480464 | Tacrolimus results in decreased expression of IGFBP1 mRNA | CTD | PMID:21865292 |
| tacrolimus hydrate | increases expression | ISO | RGD:2872 | 6480464 | Tacrolimus results in increased expression of IGFBP1 mRNA | CTD | PMID:21865292 |
| tamoxifen | multiple interactions | ISO | RGD:69038 | 6480464 | [bicalutamide co-treated with Tamoxifen] results in increased expression of IGFBP1 protein | CTD | PMID:16847815 |
| tamoxifen | affects expression | EXP | | 6480464 | Tamoxifen affects the expression of IGFBP1 mRNA | CTD | PMID:20937368 |
| testosterone | multiple interactions | ISO | RGD:69038 | 6480464 | [Testosterone co-treated with Calcitriol] results in increased expression of IGFBP1 mRNA | CTD | PMID:21592394 |
| testosterone | decreases expression | ISO | RGD:69038 | 6480464 | Testosterone results in decreased expression of IGFBP1 mRNA | CTD | PMID:21592394 |
| tetrachloromethane | affects expression | ISO | RGD:2872 | 6480464 | Carbon Tetrachloride affects the expression of IGFBP1 mRNA | CTD | PMID:15963342 |
| tetrachloromethane | increases expression | ISO | RGD:2872 | 6480464 | Carbon Tetrachloride results in increased expression of IGFBP1 mRNA | CTD | PMID:15070850 PMID:17522070 |
| tetrachloromethane | increases expression | ISO | RGD:2872 | 6480464 | Carbon Tetrachloride results in increased expression of IGFBP1 mRNA | CTD | PMID:17522070 PMID:15070850 |
| tetracycline | increases expression | ISO | RGD:2872 | 6480464 | Tetracycline results in increased expression of IGFBP1 mRNA | CTD | PMID:17522070 |
| thioacetamide | increases expression | ISO | RGD:69038 | 6480464 | Thioacetamide results in increased expression of IGFBP1 mRNA | CTD | PMID:11793227 |
| thioacetamide | increases expression | ISO | RGD:2872 | 6480464 | Thioacetamide results in increased expression of IGFBP1 mRNA | CTD | PMID:16297948 |
| thioacetamide | decreases expression | ISO | RGD:2872 | 6480464 | Thioacetamide results in decreased expression of IGFBP1 mRNA | CTD | PMID:14739098 |
| thioacetamide | multiple interactions | ISO | RGD:2872 | 6480464 | halofuginone inhibits the reaction [Thioacetamide results in decreased expression of IGFBP1 mRNA] | CTD | PMID:14739098 |
| trans-resveratrol | multiple interactions | ISO | RGD:2872 | 6480464 | resveratrol inhibits the reaction [INS1 protein results in decreased expression of IGFBP1 mRNA] | CTD | PMID:16626303 |
| trans-resveratrol | increases expression | ISO | RGD:69038 | 6480464 | resveratrol results in increased expression of IGFBP1 mRNA | CTD | PMID:12154049 |
| trans-resveratrol | multiple interactions | ISO | RGD:2872 | 6480464 | FOXO1 protein affects the reaction [resveratrol results in increased expression of IGFBP1 mRNA] | CTD | PMID:15788402 |
| trans-resveratrol | increases expression | ISO | RGD:2872 | 6480464 | resveratrol results in increased expression of IGFBP1 mRNA | CTD | PMID:16236254 |
| trans-resveratrol | multiple interactions | EXP | | 6480464 | resveratrol promotes the reaction [FOXO1 protein results in increased expression of IGFBP1 mRNA] | CTD | PMID:16917544 |
| troglitazone | increases expression | ISO | RGD:69038 | 6480464 | troglitazone results in increased expression of IGFBP1 mRNA | CTD | PMID:12659874 |
| troglitazone | increases secretion | ISO | RGD:69038 | 6480464 | troglitazone results in increased secretion of IGFBP1 protein | CTD | PMID:12659874 |
| ursodeoxycholic acid | increases expression | ISO | RGD:2872 | 6480464 | Ursodeoxycholic Acid results in increased expression of IGFBP1 mRNA | CTD | PMID:15885361 |
| valproic acid | affects expression | EXP | | 6480464 | Valproic Acid affects the expression of IGFBP1 mRNA | CTD | PMID:17963808 |
| vancomycin | affects expression | ISO | RGD:2872 | 6480464 | Vancomycin affects the expression of IGFBP1 mRNA | CTD | PMID:18289764 |
| vancomycin | increases expression | EXP | | 6480464 | Vancomycin results in increased expression of IGFBP1 mRNA | CTD | PMID:18930951 |
| zinc atom | decreases expression | ISO | RGD:2872 | 6480464 | Zinc deficiency results in decreased expression of IGFBP1 protein | CTD | PMID:12672911 PMID:20404036 |
| zinc atom | decreases expression | ISO | RGD:2872 | 6480464 | Zinc deficiency results in decreased expression of IGFBP1 mRNA; more ... | CTD | PMID:12672911 |
| zinc(0) | decreases expression | ISO | RGD:2872 | 6480464 | Zinc deficiency results in decreased expression of IGFBP1 protein | CTD | PMID:12672911 PMID:20404036 |
| zinc(0) | decreases expression | ISO | RGD:2872 | 6480464 | Zinc deficiency results in decreased expression of IGFBP1 mRNA; more ... | CTD | PMID:12672911 |